tiprankstipranks
Trending News
More News >
uniQure N.V. (QURE)
NASDAQ:QURE
US Market

uniQure (QURE) Stock Forecast & Price Target

Compare
1,435 Followers
See the Price Targets and Ratings of:

QURE Analyst Ratings

Moderate Buy
12Ratings
Moderate Buy
4 Buy
8 Hold
0 Sell
Based on 12 analysts giving stock ratings to
uniQure
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

QURE Stock 12 Month Forecast

Average Price Target

$24.00
▲(128.57% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for uniQure in the last 3 months. The average price target is $24.00 with a high forecast of $70.00 and a low forecast of $9.00. The average price target represents a 128.57% change from the last price of $10.50.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"8":"$8","71":"$71","23.75":"$23.8","39.5":"$39.5","55.25":"$55.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":70,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$70.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":24,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$24.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":9,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$9.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[8,23.75,39.5,55.25,71],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.5,15.076923076923077,19.653846153846153,24.23076923076923,28.807692307692307,33.38461538461539,37.96153846153846,42.53846153846153,47.11538461538461,51.69230769230769,56.26923076923077,60.84615384615384,65.42307692307692,{"y":70,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.5,11.538461538461538,12.576923076923077,13.615384615384617,14.653846153846153,15.692307692307693,16.730769230769234,17.76923076923077,18.807692307692307,19.846153846153847,20.884615384615387,21.923076923076923,22.961538461538463,{"y":24,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.5,10.384615384615385,10.26923076923077,10.153846153846153,10.038461538461538,9.923076923076923,9.807692307692308,9.692307692307692,9.576923076923077,9.461538461538462,9.346153846153847,9.23076923076923,9.115384615384615,{"y":9,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":13.15,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.91,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.485,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.99,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.695,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.01,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.99,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.69,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.57,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.93,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.7,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.5,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$70.00Average Price Target$24.00Lowest Price Target$9.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen Analyst forecast on QURE
TD Cowen
TD Cowen
Buy
Reiterated
03/03/26
uniQure: Regulatory Setback on AMT-130 Seen as Surmountable, Supporting Buy Rating on Undervalued Long-Term Pipeline Upside
Wells Fargo Analyst forecast on QURE
Wells Fargo
Wells Fargo
$15
Hold
42.86%
Upside
Downgraded
03/03/26
uniQure downgraded to Equal Weight from Overweight at Wells FargouniQure downgraded to Equal Weight from Overweight at Wells Fargo
Goldman Sachs Analyst forecast on QURE
Goldman Sachs
Goldman Sachs
$12
Hold
14.29%
Upside
Reiterated
03/03/26
uniQure price target lowered to $9 from $37 at Goldman SachsuniQure price target lowered to $9 from $37 at Goldman Sachs
Barclays Analyst forecast on QURE
Barclays
Barclays
$31
Hold
195.24%
Upside
Reiterated
03/03/26
Barclays Reaffirms Their Hold Rating on uniQure (QURE)
Chardan Capital Analyst forecast on QURE
Chardan Capital
Chardan Capital
$53$16
Buy
52.38%
Upside
Reiterated
03/03/26
uniQure price target lowered to $16 from $53 at ChardanuniQure price target lowered to $16 from $53 at Chardan
Mizuho Securities Analyst forecast on QURE
Mizuho Securities
Mizuho Securities
$33$12
Hold
14.29%
Upside
Downgraded
03/03/26
uniQure (QURE) was downgraded to a Hold Rating at Mizuho Securities
H.C. Wainwright Analyst forecast on QURE
H.C. Wainwright
H.C. Wainwright
$70
Buy
566.67%
Upside
Reiterated
03/02/26
H.C. Wainwright says uniQure may be able to negotiate alternative path with FDAH.C. Wainwright says uniQure may be able to negotiate alternative path with FDA
Cantor Fitzgerald Analyst forecast on QURE
Cantor Fitzgerald
Cantor Fitzgerald
$55$9
Hold
-14.29%
Downside
Downgraded
03/02/26
uniQure downgraded to Neutral from Overweight at Cantor FitzgeralduniQure downgraded to Neutral from Overweight at Cantor Fitzgerald
Stifel Nicolaus Analyst forecast on QURE
Stifel Nicolaus
Stifel Nicolaus
$40
Buy
280.95%
Upside
Assigned
03/02/26
uniQure price target lowered to $14 from $40 at StifeluniQure price target lowered to $14 from $40 at Stifel
RBC Capital Analyst forecast on QURE
RBC Capital
RBC Capital
$45$11
Hold
4.76%
Upside
Downgraded
03/02/26
uniQure downgraded to Sector Perform from Outperform at RBC CapitaluniQure downgraded to Sector Perform from Outperform at RBC Capital
Wolfe Research Analyst forecast on QURE
Unknown Analyst
Wolfe Research
Not Ranked
Wolfe Research
Hold
Initiated
02/23/26
uniQure initiated with a Peer Perform at Wolfe ResearchuniQure initiated with a Peer Perform at Wolfe Research
William Blair Analyst forecast on QURE
William Blair
William Blair
Hold
Reiterated
02/06/26
Balanced Risk/Reward at uniQure: Early Promise for AMT-191 Offset by Regulatory and Competitive Uncertainty Around AMT-130
Leerink Partners Analyst forecast on QURE
Leerink Partners
Leerink Partners
$68$60
Buy
471.43%
Upside
Reiterated
11/10/25
uniQure's AMT-130: A Promising Breakthrough in Huntington's Disease Treatment Amidst Regulatory Challenges
Guggenheim
$28$95
Buy
804.76%
Upside
Reiterated
09/24/25
uniQure price target raised to $95 from $28 at GuggenheimuniQure price target raised to $95 from $28 at Guggenheim
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TD Cowen Analyst forecast on QURE
TD Cowen
TD Cowen
Buy
Reiterated
03/03/26
uniQure: Regulatory Setback on AMT-130 Seen as Surmountable, Supporting Buy Rating on Undervalued Long-Term Pipeline Upside
Wells Fargo Analyst forecast on QURE
Wells Fargo
Wells Fargo
$15
Hold
42.86%
Upside
Downgraded
03/03/26
uniQure downgraded to Equal Weight from Overweight at Wells FargouniQure downgraded to Equal Weight from Overweight at Wells Fargo
Goldman Sachs Analyst forecast on QURE
Goldman Sachs
Goldman Sachs
$12
Hold
14.29%
Upside
Reiterated
03/03/26
uniQure price target lowered to $9 from $37 at Goldman SachsuniQure price target lowered to $9 from $37 at Goldman Sachs
Barclays Analyst forecast on QURE
Barclays
Barclays
$31
Hold
195.24%
Upside
Reiterated
03/03/26
Barclays Reaffirms Their Hold Rating on uniQure (QURE)
Chardan Capital Analyst forecast on QURE
Chardan Capital
Chardan Capital
$53$16
Buy
52.38%
Upside
Reiterated
03/03/26
uniQure price target lowered to $16 from $53 at ChardanuniQure price target lowered to $16 from $53 at Chardan
Mizuho Securities Analyst forecast on QURE
Mizuho Securities
Mizuho Securities
$33$12
Hold
14.29%
Upside
Downgraded
03/03/26
uniQure (QURE) was downgraded to a Hold Rating at Mizuho Securities
H.C. Wainwright Analyst forecast on QURE
H.C. Wainwright
H.C. Wainwright
$70
Buy
566.67%
Upside
Reiterated
03/02/26
H.C. Wainwright says uniQure may be able to negotiate alternative path with FDAH.C. Wainwright says uniQure may be able to negotiate alternative path with FDA
Cantor Fitzgerald Analyst forecast on QURE
Cantor Fitzgerald
Cantor Fitzgerald
$55$9
Hold
-14.29%
Downside
Downgraded
03/02/26
uniQure downgraded to Neutral from Overweight at Cantor FitzgeralduniQure downgraded to Neutral from Overweight at Cantor Fitzgerald
Stifel Nicolaus Analyst forecast on QURE
Stifel Nicolaus
Stifel Nicolaus
$40
Buy
280.95%
Upside
Assigned
03/02/26
uniQure price target lowered to $14 from $40 at StifeluniQure price target lowered to $14 from $40 at Stifel
RBC Capital Analyst forecast on QURE
RBC Capital
RBC Capital
$45$11
Hold
4.76%
Upside
Downgraded
03/02/26
uniQure downgraded to Sector Perform from Outperform at RBC CapitaluniQure downgraded to Sector Perform from Outperform at RBC Capital
Wolfe Research Analyst forecast on QURE
Unknown Analyst
Wolfe Research
Not Ranked
Wolfe Research
Hold
Initiated
02/23/26
uniQure initiated with a Peer Perform at Wolfe ResearchuniQure initiated with a Peer Perform at Wolfe Research
William Blair Analyst forecast on QURE
William Blair
William Blair
Hold
Reiterated
02/06/26
Balanced Risk/Reward at uniQure: Early Promise for AMT-191 Offset by Regulatory and Competitive Uncertainty Around AMT-130
Leerink Partners Analyst forecast on QURE
Leerink Partners
Leerink Partners
$68$60
Buy
471.43%
Upside
Reiterated
11/10/25
uniQure's AMT-130: A Promising Breakthrough in Huntington's Disease Treatment Amidst Regulatory Challenges
Guggenheim
$28$95
Buy
804.76%
Upside
Reiterated
09/24/25
uniQure price target raised to $95 from $28 at GuggenheimuniQure price target raised to $95 from $28 at Guggenheim
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering uniQure

3 Months
xxx
Success Rate
17/35 ratings generated profit
49%
Average Return
+5.63%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 48.57% of your transactions generating a profit, with an average return of +5.63% per trade.
1 Year
Success Rate
18/35 ratings generated profit
51%
Average Return
+21.23%
a rating ―
Copying Debjit Chattopadhyay's trades and holding each position for 1 Year would result in 51.43% of your transactions generating a profit, with an average return of +21.23% per trade.
2 Years
xxx
Success Rate
17/35 ratings generated profit
49%
Average Return
+10.21%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 48.57% of your transactions generating a profit, with an average return of +10.21% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

QURE Analyst Recommendation Trends

Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
12
11
13
9
8
Buy
17
5
2
1
2
Hold
4
4
5
4
9
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
33
20
20
14
19
In the current month, QURE has received 10 Buy Ratings, 9 Hold Ratings, and 0 Sell Ratings. QURE average Analyst price target in the past 3 months is 24.00.
Each month's total comprises the sum of three months' worth of ratings.

QURE Financial Forecast

QURE Earnings Forecast

Next quarter’s earnings estimate for QURE is -$0.87 with a range of -$1.13 to -$0.54. The previous quarter’s EPS was -$0.57. QURE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year QURE has Performed in-line its overall industry.
Next quarter’s earnings estimate for QURE is -$0.87 with a range of -$1.13 to -$0.54. The previous quarter’s EPS was -$0.57. QURE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year QURE has Performed in-line its overall industry.

QURE Sales Forecast

Next quarter’s sales forecast for QURE is $5.78M with a range of $2.00M to $14.20M. The previous quarter’s sales results were ―. QURE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year QURE has Performed in-line its overall industry.
Next quarter’s sales forecast for QURE is $5.78M with a range of $2.00M to $14.20M. The previous quarter’s sales results were ―. QURE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year QURE has Performed in-line its overall industry.

QURE Stock Forecast FAQ

What is QURE’s average 12-month price target, according to analysts?
Based on analyst ratings, uniQure N.V.’s 12-month average price target is 24.00.
    What is QURE’s upside potential, based on the analysts’ average price target?
    uniQure N.V. has 128.57% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is QURE a Buy, Sell or Hold?
          uniQure N.V. has a consensus rating of Moderate Buy which is based on 4 buy ratings, 8 hold ratings and 0 sell ratings.
            What is uniQure N.V.’s price target?
            The average price target for uniQure N.V. is 24.00. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $70.00 ,the lowest forecast is $9.00. The average price target represents 128.57% Increase from the current price of $10.5.
              What do analysts say about uniQure N.V.?
              uniQure N.V.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of QURE?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.